Preexisting plasma cell disorders, such as monoclonal gammopathy of undetermined significance (MGUS) or smoldering multiple myeloma (SMM), are identified in at least one-third of patients with multiple myeloma (MM).

Read More> https://multiplemyeloma.pocn.com/patient-management/revealing-multiple-myeloma-origins-premalignant-disorders-and-biomarker-advances/